BIND Therapeutics Announces Completion of Collaboration Agreement with Amgen

03-07-2014 Business Wire HealthComments (0)

AmgenBiotechnologyPharmaceutical

Bind Therapeutics announced today the completion of its collaborative research program with Amgen Inc. originally entered into in January 2013.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top